 | BRIEF-Brainstorm Cell Files Prospectus Supplement Offering 2.5 Mln Shares
www.reuters.com - July 4 at 12:29 PM |
 | BrainStorm Announces Completion of All Dosing in NurOwn® Phase 3 Clinical Trial in ALS
finance.yahoo.com - July 2 at 11:51 AM |
| BrainStorm to Showcase Alzheimer's Disease Clinical Program in KOL Webinar
finance.yahoo.com - July 1 at 12:49 PM |
 | Brainstorm Cell Therapeutics (NASDAQ:BCLI) Upgraded to Strong-Buy by BidaskClub
www.marketbeat.com - June 26 at 5:12 AM |
 | BrainStorm Expands Clinical Pipeline to Evaluate NurOwn® for the Treatment of Alzheimer's Disease
www.prnewswire.com - June 24 at 10:22 AM |
 | BrainStorm to develop NurOwn for Alzheimer's
seekingalpha.com - June 24 at 10:22 AM |
| BrainStorm Expands Clinical Pipeline to Evaluate NurOwn® for the Treatment of Alzheimer's Disease
finance.yahoo.com - June 24 at 10:22 AM |
| BrainStorm to study stem cell treatment in Alzheimer's patients
finance.yahoo.com - June 24 at 10:22 AM |
| BrainStorm Cell to join Russell 2000 and 3000 indexes
seekingalpha.com - June 23 at 8:10 AM |
| BrainStorm Cell Therapeutics to Join the Russell 2000® Index and Russell 3000® Index
finance.yahoo.com - June 23 at 8:10 AM |
|
 | Zacks: Brokerages Anticipate Brainstorm Cell Therapeutics Inc (NASDAQ:BCLI) Will Announce Earnings of -$0.24 Per Share
www.americanbankingnews.com - June 16 at 1:25 PM |
 | Will the Brainstorm Cell Therapeutics Inc (NAQ:BCLI) share price keep rising?
uk.finance.yahoo.com - June 16 at 8:32 AM |
| BrainStorm Granted SME Status by the European Medicines Agency
finance.yahoo.com - June 15 at 2:20 PM |
| BrainStorm to Present at the Raymond James Human Health Innovations Conference
finance.yahoo.com - June 11 at 10:24 AM |
| BCLI: ALS Association and I AM ALS Awards $500,000 Grant; Potential Inclusion in Russell 3000 Index…
finance.yahoo.com - June 10 at 12:49 PM |
| The ALS Association, I AM ALS Award BrainStorm Cell Therapeutics $500,000 for ALS Biomarker Study
finance.yahoo.com - June 9 at 7:48 AM |
| Hedge Funds Warming Up To Brainstorm Cell Therapeutics Inc. (BCLI)
finance.yahoo.com - June 4 at 7:41 PM |
| BrainStorm to Participate in BIO Digital 2020
finance.yahoo.com - June 3 at 8:26 AM |
| BrainStorm Announces that Pivotal Phase 3 Trial Remains on Track for Topline Data in Q4-2020
finance.yahoo.com - June 2 at 9:27 AM |
| BrainStorm Appoints Pharmaceutical Veteran Stacy R. Lindborg, Ph.D. as Executive Vice President, Head of Global Clinical Research
finance.yahoo.com - May 27 at 8:55 AM |
| Does The Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) Share Price Tend To Follow The Market?
finance.yahoo.com - May 18 at 7:46 AM |
| BrainStorm Cell Therapeutics Inc. (BCLI) CEO Chaim Lebovits on Q1 2020 Results - Earnings Call Transcript
seekingalpha.com - May 10 at 8:39 PM |
| BCLI: The Countdown to Phase 3 ALS Data Begins…
finance.yahoo.com - May 8 at 3:31 PM |
| BrainStorm Cell Therapeutics EPS misses by $0.10
seekingalpha.com - May 7 at 12:12 PM |
| BrainStorm Leases a New Cleanroom Facility at The Tel Aviv Sourasky Medical Center to Manufacture NurOwn® for The European Union
finance.yahoo.com - May 7 at 6:18 AM |
| BrainStorm Presents New Data Highlighting NurOwn® Immunomodulation in Neurology
finance.yahoo.com - May 4 at 7:46 AM |
| BrainStorm-Cell Therapeutics to Announce First Quarter Financial Results and Provide a Corporate Update
finance.yahoo.com - April 29 at 8:59 AM |
| BCLI: $1.5M Grant from Israel Innovation Authority…
finance.yahoo.com - April 8 at 2:32 PM |
| BrainStorm Cell +4% premarket on $1.5M grant
seekingalpha.com - April 3 at 7:36 AM |
| BrainStorm Awarded $1.5 Million Non-Dilutive Grant for 2020 by the Israel Innovation Authority
finance.yahoo.com - April 3 at 7:36 AM |
|
| David Setboun Joins BrainStorm as Executive Vice President and Chief Operating Officer
finance.yahoo.com - April 1 at 4:16 PM |
 | Brainstorm Cell Therapeutics Inc.
www.wsj.com - March 27 at 10:38 PM |
| Brainstorm Cell Therapeutics Inc. (BCLI)
finance.yahoo.com - March 22 at 11:00 PM |
| Brainstorm Cell Therapeutics up 4% on capital raise
seekingalpha.com - March 6 at 1:17 PM |
| BrainStorm Cell Therapeutics Raises $10.0 Million in Common Stock Sale at $8.00 Per Share
finance.yahoo.com - March 6 at 1:17 PM |
| Fifth and Final Site Announced for BrainStorm’s Progressive Multiple Sclerosis Phase 2 Clinical Trial
finance.yahoo.com - February 27 at 7:23 AM |
| Thinking about buying stock in Brainstorm Cell Therapeutics, HP, Plug Power, Virgin Galactic, or Zoom Video Communications?
www.prnewswire.com - February 25 at 1:59 PM |
| BCLI: Phase 3 ALS Results in 4Q20…
finance.yahoo.com - February 20 at 12:44 PM |
| BrainStorm Announces Operational Highlights and Financial Results for the Year Ended December 31, 2019
finance.yahoo.com - February 18 at 7:31 AM |
| BrainStorm’s Chief Operating Officer to Present at Noble Capital Markets’ Sixteenth Annual Investor Conference
finance.yahoo.com - February 17 at 4:20 AM |
| Brainstorm Cell Therapeutics (BCLI) Presents At 2020 BIO CEO & Investor Conference - Slideshow
seekingalpha.com - February 13 at 5:15 PM |
| BrainStorm Cell and FDA to discuss NurOwn regulatory pathways in ALS
seekingalpha.com - February 11 at 7:33 AM |
 | BrainStorm Cell Therapeutics and FDA Agree to Potential NurOwn(R) Regulatory Pathway for Approval in ALS
www.marketwatch.com - February 11 at 7:33 AM |
| BrainStorm Cell Therapeutics and FDA Agree to Potential NurOwn® Regulatory Pathway for Approval in ALS
finance.yahoo.com - February 11 at 7:33 AM |
| BrainStorm Cell Therapeutics to Announce Fourth Quarter and Full Year 2019 Financial Results and Provide a Corporate Update
finance.yahoo.com - February 10 at 9:25 AM |
| BrainStorm Receives Notice of Intention to Grant Additional EU patent for NurOwn®
finance.yahoo.com - January 29 at 9:13 AM |
| BrainStorm Cell Therapeutic’s COO and CMO, Dr. Ralph Kern, to Present at the 10th Annual California ALS Research Summit
finance.yahoo.com - January 21 at 3:52 PM |
| How Many Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) Shares Did Insiders Buy, In The Last Year?
finance.yahoo.com - January 17 at 9:51 AM |
| Reading Up On Brainstorm Cell Therapeutics
seekingalpha.com - December 29 at 4:00 PM |
| NurOwn® Data Safety Monitoring Board Recommends MS Phase 2 Clinical Trial Continue
finance.yahoo.com - December 19 at 8:20 AM |
